Inogen (INGN) Gross Margin (2013 - 2026)
Inogen's (INGN) quarterly Gross Margin came in at 44.49% in Q1 2026, up 28.0% year-on-year from 34.76% in Q1 2025, and up 3.18% on a QoQ basis from 43.12% in Q4 2025.
Inogen (INGN) Gross Margin (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Gross Margin data on file, last reported at 44.49% in Q1 2026.
- On a quarterly basis, Gross Margin rose 28.0% year-over-year to 44.49% in Q1 2026; TTM through Mar 2026 was 44.31%, a 179.0% decrease from a year earlier, with the FY2025 full-year figure at 44.24%, down 185.0% from the prior year.
- Gross Margin for Q1 2026 stood at 44.49%, up from 43.12% in the prior quarter.
- Over the last five years, Gross Margin for INGN reached as high as 48.15% in Q2 2024 and fell as low as 33.46% in Q4 2022.
- Historically, Gross Margin has averaged 42.84% across 5 years, with a median of 44.05% in 2024.
- Across the five-year window, Gross Margin slumped 1828 bps in 2022 and surged 821 bps in 2024, its largest moves.
- Year by year, Gross Margin stood at 33.46% in 2022, then gained by 11 bps to 37.1% in 2023, then gained by 22 bps to 45.32% in 2024, then fell by 5 bps to 43.12% in 2025, then climbed by 3 bps to 44.49% in 2026.
- Per Business Quant data, the three most recent Gross Margin figures were 44.49% in Q1 2026, 43.12% in Q4 2025, and 44.72% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Inogen | 172.68 Mn | 62.51 Mn | 37.86 Mn | 44.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.49% |
| Dec 31, 2025 | 43.12% |
| Sep 30, 2025 | 44.72% |
| Jun 30, 2025 | 44.80% |
| Mar 31, 2025 | 44.21% |
| Dec 31, 2024 | 45.32% |
| Sep 30, 2024 | 46.54% |
| Jun 30, 2024 | 48.15% |
| Mar 31, 2024 | 44.05% |
| Dec 31, 2023 | 37.10% |
| Sep 30, 2023 | 40.21% |
| Jun 30, 2023 | 40.71% |
| Mar 31, 2023 | 42.59% |
| Dec 31, 2022 | 33.46% |
| Sep 30, 2022 | 40.61% |
| Jun 30, 2022 | 44.75% |
| Mar 31, 2022 | 43.55% |
| Dec 31, 2021 | 35.19% |
| Sep 30, 2021 | 58.89% |
| Jun 30, 2021 | 49.56% |